| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in MAZE over the last quarter tilts toward selling: insiders offloaded a net 227,492 shares worth roughly $6.1M. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MAZE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.47M | - | - | |
| CEO | 191.4K | $5.17M | -34,501 | |
| Pres | 144.5K | - | -16,141 | |
| CFO | 40.0K | - | - | |
| Other | 39.8K | $414.9K | -7,500 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Bachrodt Amy60 | SVP, Finance | Sale+OE | 5,000 | $45.20 | $226,010.60 | -27.8% | -44.2% | - | |
| Feb 27, 2026 | Dandekar Atul | Csbo | Sale+OE | 7,500 | $45.43 | $340,723.24 | -41.7% | -42.0% | - | |
| Feb 2, 2026 | Bachrodt Amy60 | SVP, Finance | Sale+OE | 5,000 | $46.04 | $230,219.32 | -27.8% | -42.1% | - | |
| Feb 2, 2026 | Bernstein Harold64 | President, R&D &CMO | Sale+OE | 15,000 | $46.02 | $690,333.75 | -100% | -42.1% | - | |
| Jan 29, 2026 | Dandekar Atul | Csbo | Sale+OE | 7,500 | $44.27 | $331,990.33 | -41.7% | -42.9% | - | |
| Jan 22, 2026 | Bachrodt Amy60 | SVP, Finance | Sale+OE | 5,000 | $45.52 | $227,612.00 | -27.8% | -42.6% | - | |
| Jan 7, 2026 | Bernstein Harold64 | President, R&D &CMO | Sale+OE | 25,156 | $40.20 | $1,011,298.87 | -100% | -29.8% | - | |
| Jan 7, 2026 | Sohn Catherine A.55 | Director | Sale+OE | 29,413 | $39.07 | $1,149,054.36 | -100% | -29.8% | - | |
| Jan 5, 2026 | Bernstein Harold64 | President, R&D &CMO | Sale+OE | 4,844 | $40.39 | $195,667.53 | -100% | -24.9% | - | |
| Jan 2, 2026 | Bachrodt Amy60 | SVP, Finance | Sale+OE | 5,000 | $39.15 | $195,753.59 | -27.8% | -27.8% | - |